Does TIRZEPATIDE Cause Hypovolaemia? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Hypovolaemia have been filed in association with TIRZEPATIDE (Zepbound). This represents 0.0% of all adverse event reports for TIRZEPATIDE.
28
Reports of Hypovolaemia with TIRZEPATIDE
0.0%
of all TIRZEPATIDE reports
0
Deaths
12
Hospitalizations
How Dangerous Is Hypovolaemia From TIRZEPATIDE?
Of the 28 reports, 12 (42.9%) required hospitalization.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Injection site erythema (3,844)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which TIRZEPATIDE Alternatives Have Lower Hypovolaemia Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC